Literature DB >> 30762437

Impact of Human Factors Testing on Medical Device Design: Validation of an Automated CGM Sensor Applicator.

Robert North1, Christine Pospisil2, Ryan J Clukey3, Christopher G Parkin4.   

Abstract

Improving user engagement with continuous glucose monitoring (CGM) is considered a major requirement for achieving optimal treatment efficacy. Human factors testing is needed to ensure that CGM product designs and requisite training simplify the user experience and enhance usability and patient safety. Dexcom, Inc, recently introduced a novel, "one-button" automatic sensor applicator (ASA) for use with the Dexcom G6 (rtCGM) system. The device was developed utilizing all phases of the human factors testing process. We recruited eight certified diabetes educators from independent health care institutions to conduct a comparative ease-of-use analysis to confirm the usability of the ASA. Participants judged the instructions and device to be easier to use than the previous sensor applicator.

Entities:  

Keywords:  diabetes; human factors; rtCGM; sensor; training; usability

Year:  2019        PMID: 30762437      PMCID: PMC6955460          DOI: 10.1177/1932296819831071

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  11 in total

1.  Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.

Authors:  Roy W Beck; Tonya D Riddlesworth; Katrina J Ruedy; Craig Kollman; Andrew J Ahmann; Richard M Bergenstal; Anuj Bhargava; Bruce W Bode; Stacie Haller; Davida F Kruger; Janet B McGill; William Polonsky; David Price; Elena Toschi
Journal:  Lancet Diabetes Endocrinol       Date:  2017-07-12       Impact factor: 32.069

2.  Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.

Authors:  Roy W Beck; Tonya D Riddlesworth; Katrina Ruedy; Andrew Ahmann; Stacie Haller; Davida Kruger; Janet B McGill; William Polonsky; David Price; Stephen Aronoff; Ronnie Aronson; Elena Toschi; Craig Kollman; Richard Bergenstal
Journal:  Ann Intern Med       Date:  2017-08-22       Impact factor: 25.391

3.  Perceived accuracy in continuous glucose monitoring: understanding the impact on patients.

Authors:  William H Polonsky; Danielle Hessler
Journal:  J Diabetes Sci Technol       Date:  2014-11-10

4.  Continuous Glucose Monitoring in Type 1 Diabetes.

Authors:  Uirassu Borges; Thomas Kubiak
Journal:  J Diabetes Sci Technol       Date:  2016-05

5.  The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial.

Authors:  William H Polonsky; Danielle Hessler; Katrina J Ruedy; Roy W Beck
Journal:  Diabetes Care       Date:  2017-04-07       Impact factor: 19.112

6.  Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.

Authors:  Marcus Lind; William Polonsky; Irl B Hirsch; Tim Heise; Jan Bolinder; Sofia Dahlqvist; Erik Schwarz; Arndís Finna Ólafsdóttir; Anders Frid; Hans Wedel; Elsa Ahlén; Thomas Nyström; Jarl Hellman
Journal:  JAMA       Date:  2017-01-24       Impact factor: 56.272

7.  What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users.

Authors:  William H Polonsky; Danielle Hessler
Journal:  Diabetes Technol Ther       Date:  2013-02-21       Impact factor: 6.118

8.  Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.

Authors:  Jan Šoupal; Lenka Petruželková; Milan Flekač; Tomáš Pelcl; Martin Matoulek; Martina Daňková; Jan Škrha; Štěpán Svačina; Martin Prázný
Journal:  Diabetes Technol Ther       Date:  2016-08-02       Impact factor: 6.118

9.  Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial.

Authors:  Thomas Haak; Hélène Hanaire; Ramzi Ajjan; Norbert Hermanns; Jean-Pierre Riveline; Gerry Rayman
Journal:  Diabetes Ther       Date:  2016-12-20       Impact factor: 2.945

10.  The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.

Authors:  T Battelino; I Conget; B Olsen; I Schütz-Fuhrmann; E Hommel; R Hoogma; U Schierloh; N Sulli; J Bolinder
Journal:  Diabetologia       Date:  2012-09-11       Impact factor: 10.122

View more
  2 in total

1.  The Lifebox Surgical Headlight Project: engineering, testing, and field assessment in a resource-constrained setting.

Authors:  N Starr; N Panda; E W Johansen; J A Forrester; E Wayessa; D Rebollo; A August; K Fernandez; S Bitew; T Negussie Mammo; T G Weiser
Journal:  Br J Surg       Date:  2020-06-27       Impact factor: 6.939

2.  Input of Patients for New Diabetes Technology Products.

Authors:  Lutz Heinemann; David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2021-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.